Elma Hawkins Email

President and Founder . Redpin Therapeutics

Current Roles

Employees:
1
Revenue:
$100.5k
About
Redpin Therapeutics is a privately-held, preclinical stage gene therapy company based in New York City. We are developing a proprietary chemogenetics platform for targeted cell therapies that address currently intractable diseases of the nervous system. Our approach integrates powerful principles from synthetic biology, gene therapy, and traditional pharmacotherapy. Our science is based on the groundbreaking discovery and development of an ultrapotent ion channel-based chemogenetics platform that enables targeted cell activation or inhibition controlled by low doses of the anti-smoking drug varenicline (CHANTIX®).
Redpin Therapeutics Address
101 Sixth Avenue,
null, null
Redpin Therapeutics Email

Past Companies

Redpin Therapeutics Inc.President and Founder
Quiet TherapeuticsExecutive Chairman
Lion BiotechnologiesPresident and CEO

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.